1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. ALNYLAM PHARMACEUTICALS INC

Alnylam Pharmaceuticals Inc XNAS: ALNY

Alnylam Pharmaceuticals Inc Live Share Price Today, Share Analysis and Chart

Momentum Trap
about

Alnylam Pharmaceuticals is a leader in the study of RNA interference (RNAi) therapeutics. RNAi is a naturally occurring biological pathway within cells for sequence-specific silencing and regulation of gene expression. Alnylam has five drugs on the m...

Read More

305.31 1.54 (0.51%)

New 52W High today

562.8K XNAS Volume

XNAS 04 Jun, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Share
Board Meeting
The next board meeting for Alnylam Pharmaceuticals Inc is on 09 Jun 2025 for the purpose of Goldman Sachs 46th Annual Global Healthcare Conference See details
Durability score
Low Financial Strength
22.2 / 100
Valuation Score
Expensive Valuation
4.7 / 100
Momentum Score
Technically Moderately Bullish
63.7 / 100
Momentum Trap These stocks are with a bad quality and poor financial score ranging from medium to expensive valuation. Rising technical aspects may attract investors, but, weak financials cannot be overlooked. View Similar Embed DVM
Analyst Price Target
321
1Yr Price target upside is 5%
31 analysts

20

S

6

W

2

O

1

T

SWOT Analysis

Alnylam Pharmaceuticals Inc Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..

Alnylam Pharmaceuticals Inc FAQ

How is Alnylam Pharmaceuticals Inc today?
Alnylam Pharmaceuticals Inc today is trading in the green, and is up by 0.51% at 305.31.
Alnylam Pharmaceuticals Inc is currently trading up 0.51% on an intraday basis. In the past week the stock rose 5.24%. stock has been up 25.37% in the past quarter and rose 102.93% in the past year. You can view this in the overview section.